BiomX Inc.

NYSE
PHGE
paper.types.company
Rentabilité sur six mois: -54.56%
Rendement en dividendes: 0%
Secteur: Healthcare

0.409 $

0 $ 0%
0.409 $
2.28 $

paper.min_max_per_year

Calendrier des promotions BiomX Inc.

Calendrier avancé Graphique simple
Financial Markets by TradingView
Ajouter à la liste de comparaison
Ajouter à la liste de surveillance
Ajouter au portefeuille
Ajouter un avis de prix

Paramètres de base

IPO date
2019-03-13
ISIN
US09090D1037
Industry
Biotechnology
Sector
Health Care
Валюта
usd
Валюта отчета
usd
Сайт
lien
Tous les paramètres

Grade

Sous-estimation
Nom Signification Grade
P/S -41.98 0
P/BV 0.3972 10
P/E 0.5411 10
Efficacité
Nom Signification Grade
ROA 51.94 10
ROE 130.21 10
ROIC 0 0
Dividendes
Nom Signification Grade
Rendement en dividendes 0 0
DSI 0 0
Croissance moyenne du dividende 0 0
Devoir
Nom Signification Grade
Debt/EBITDA -0.7302 10
Debt/Ratio 0.2217 10
Debt/Equity 0.7903 9
Impulsion de croissance
Nom Signification Grade
Revenu, % 166.42 10
Ebitda, % -52.62 0
EPS, % -203.79 0
Plus de détails

paper.price.prices

Prix Common.min. Common.max. Changement paper.changes_in_industry paper.changes_in_index
common.calendar.number_days.1 0.409 $ 0 $ 0 $ 0 % 0 % 0 %
common.calendar.number_days.7d 0.44 $ 0 $ 0 $ -7.05 % 0 % 0 %
common.calendar.number_days.30d 0.519 $ 0 $ 0 $ -21.19 % 0 % 0 %
common.calendar.number_days.90d 0.538 $ 0.409 $ 0.622 $ -23.98 % 0 % 0 %
common.calendar.number_days.180d 0.9 $ 0.409 $ 1.05 $ -54.56 % 0 % 0 %
common.calendar.number_days.1y 1.4 $ 0.409 $ 2.28 $ -70.79 % 0 % 0 %
common.calendar.number_days.3y 0.6 $ 0.135 $ 3.63 $ -31.83 % 0 % 0 %
common.calendar.number_days.5y 5.43 $ 0.135 $ 8.65 $ -92.47 % 0 % 0 %
common.calendar.number_days.10y 0.135 $ 0.135 $ 10.8 $ +302.96 % 0 % 0 %
common.calendar.number_days.ytd 0.7644 $ 0.409 $ 1.05 $ -46.49 % 0 % 0 %

Principaux propriétaires

Entreprises similaires

P/E & P/BVEV/Ebitda & Debt/Ebitda


Gestion d'entreprise

Superviseur Titre d'emploi Paiement Année de naissance
Mr. Jonathan Eitan Solomon MBA CEO & Director 714.37k 1977 (48 années)
Ms. Marina Wolfson CPA CFO & Secretary 337.51k 1984 (41 année)
Dr. Merav Bassan Ph.D. Chief Development Officer 437.71k 1966 (59 années)
Prof. Rotem Sorek Ph.D. Scientific Founder N/A
Dr. Eran Elinav M.D., Ph.D. Scientific Founder N/A
Dr. Timothy K. Lu M.D., Ph.D. Scientific Founder N/A 1981 (44 année)
Ms. Inbal Benjamini-Elran C.H.R.O N/A
Mr. Assaf Oron Chief Business Officer 352.04k 1974 (51 année)

Informations sur l'entreprise

Adresse: Israel, Ness Ziona, 22 Einstein Street - Ouvrir dans google maps, Ouvrir les cartes yandex
Site web: https://www.biomx.com

À propos de l'entreprise BiomX Inc.

BiomX Inc., a clinical-stage microbiome company, develops products using natural and engineered phage technologies designed to target and kill specific harmful bacteria. It targets bacteria that affect the appearance of skin, as well as chronic diseases, such as inflammatory bowel diseases (IBD), primary sclerosing cholangitis (PSC), cystic fibrosis (CF), atopic dermatitis, and colorectal cancer (CRC). It is developing BX004, a phage therapy for CF patients with chronic Pseudomonas aeruginosa respiratory infections that is in Phase 1b/2a clinical trials. The company's pipeline products also include BX005, a topical phage cocktail, which is in Phase 1/2 clinical study that targets Staphylococcus aureus (S. aureus), a bacteria associated with the manifestation of the disease. In addition, the company engages in the provision of colorectal cancer program that utilizes engineered phage with various payloads, which are administered intravenously to target Fusobacterium nucleatum bacteria residing within the tumor microenvironment. BiomX Inc. was founded in 2015 and is headquartered in Ness Ziona, Israel.